Clinical Trial: A Phase 1, Study of the Safety and Tolerability of ALV003 in Healthy Adult Volunteers and Subjects With Well-Controlled Celiac Disease
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Phase 1, Two Stage, Single Dose, Single-Blind, Placebo Controlled, Dose Escalation, Crossover Study of the Safety and Tolerability of ALV003 in Healthy Adult Volunteers and Subjects With Well-Contro
Brief Summary: To assess safety and tolerability of ALV003 in healthy volunteers and patients with Celiac Disease
Detailed Summary: A Phase 1, Two Stage, Single Dose, Single-Blind, Placebo Controlled, Dose Escalation, Crossover Study of the Safety and Tolerability of ALV003 in Healthy Adult Volunteers and Subjects With Well-Controlled Celiac Disease
Sponsor: Alvine Pharmaceuticals Inc.
Current Primary Outcome: safety and tolerability [ Time Frame: Throughout ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Alvine Pharmaceuticals Inc.
Dates:
Date Received: February 13, 2008
Date Started: February 2008
Date Completion:
Last Updated: August 17, 2009
Last Verified: August 2009